vs

Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and Barnes & Noble Education, Inc. (BNED). Click either name above to swap in a different company.

Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $598.2M, roughly 1.4× Barnes & Noble Education, Inc.). Barnes & Noble Education, Inc. runs the higher net margin — 4.2% vs 0.5%, a 3.6% gap on every dollar of revenue. On growth, Acadia Healthcare Company, Inc. posted the faster year-over-year revenue change (7.5% vs 6.9%). Over the past eight quarters, Barnes & Noble Education, Inc.'s revenue compounded faster (20.0% CAGR vs 2.0%).

Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.

Barnes & Noble Booksellers is an American bookseller with the largest number of retail outlets in the United States. The company operates approximately 700+ retail stores across the United States.

ACHC vs BNED — Head-to-Head

Bigger by revenue
ACHC
ACHC
1.4× larger
ACHC
$829.0M
$598.2M
BNED
Growing faster (revenue YoY)
ACHC
ACHC
+0.6% gap
ACHC
7.5%
6.9%
BNED
Higher net margin
BNED
BNED
3.6% more per $
BNED
4.2%
0.5%
ACHC
Faster 2-yr revenue CAGR
BNED
BNED
Annualised
BNED
20.0%
2.0%
ACHC

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
ACHC
ACHC
BNED
BNED
Revenue
$829.0M
$598.2M
Net Profit
$4.5M
$25.0M
Gross Margin
21.7%
Operating Margin
6.8%
Net Margin
0.5%
4.2%
Revenue YoY
7.5%
6.9%
Net Profit YoY
-50.8%
-49.7%
EPS (diluted)
$0.05
$0.72

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACHC
ACHC
BNED
BNED
Q1 26
$829.0M
Q4 25
$821.5M
$598.2M
Q3 25
$851.6M
$274.2M
Q2 25
$869.2M
$233.0M
Q1 25
$770.5M
$419.7M
Q4 24
$774.2M
$559.7M
Q3 24
$815.6M
$250.9M
Q2 24
$796.0M
$192.7M
Net Profit
ACHC
ACHC
BNED
BNED
Q1 26
$4.5M
Q4 25
$-1.2B
$25.0M
Q3 25
$36.2M
$-18.3M
Q2 25
$30.1M
$-23.0M
Q1 25
$8.4M
$17.9M
Q4 24
$32.6M
$43.2M
Q3 24
$68.1M
$-103.9M
Q2 24
$78.5M
$-41.9M
Gross Margin
ACHC
ACHC
BNED
BNED
Q1 26
Q4 25
21.7%
Q3 25
20.2%
Q2 25
30.3%
Q1 25
22.3%
Q4 24
23.0%
Q3 24
17.9%
Q2 24
28.7%
Operating Margin
ACHC
ACHC
BNED
BNED
Q1 26
Q4 25
-142.4%
6.8%
Q3 25
4.7%
-8.4%
Q2 25
5.8%
-4.9%
Q1 25
1.7%
4.5%
Q4 24
4.9%
8.4%
Q3 24
12.1%
-15.4%
Q2 24
13.4%
-16.3%
Net Margin
ACHC
ACHC
BNED
BNED
Q1 26
0.5%
Q4 25
-143.3%
4.2%
Q3 25
4.3%
-6.7%
Q2 25
3.5%
-9.9%
Q1 25
1.1%
4.3%
Q4 24
4.2%
7.7%
Q3 24
8.4%
-41.4%
Q2 24
9.9%
-21.7%
EPS (diluted)
ACHC
ACHC
BNED
BNED
Q1 26
$0.05
Q4 25
$-12.98
$0.72
Q3 25
$0.40
$-0.54
Q2 25
$0.33
$2.97
Q1 25
$0.09
$0.59
Q4 24
$0.36
$1.63
Q3 24
$0.74
$-7.69
Q2 24
$0.85
$-15.68

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACHC
ACHC
BNED
BNED
Cash + ST InvestmentsLiquidity on hand
$158.5M
$11.7M
Total DebtLower is stronger
$2.5B
$122.5M
Stockholders' EquityBook value
$2.0B
$283.2M
Total Assets
$5.5B
$1.1B
Debt / EquityLower = less leverage
1.29×
0.43×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACHC
ACHC
BNED
BNED
Q1 26
$158.5M
Q4 25
$133.2M
$11.7M
Q3 25
$118.7M
$7.3M
Q2 25
$131.4M
$9.1M
Q1 25
$91.2M
$9.2M
Q4 24
$76.3M
$11.6M
Q3 24
$82.1M
$8.2M
Q2 24
$77.2M
$10.5M
Total Debt
ACHC
ACHC
BNED
BNED
Q1 26
$2.5B
Q4 25
$2.5B
$122.5M
Q3 25
$2.3B
$170.0M
Q2 25
$2.3B
$103.1M
Q1 25
$2.2B
$141.2M
Q4 24
$2.0B
$177.6M
Q3 24
$1.9B
$221.9M
Q2 24
$1.8B
$196.3M
Stockholders' Equity
ACHC
ACHC
BNED
BNED
Q1 26
$2.0B
Q4 25
$1.9B
$283.2M
Q3 25
$3.1B
$256.5M
Q2 25
$3.1B
$272.2M
Q1 25
$3.0B
$292.9M
Q4 24
$3.1B
$211.4M
Q3 24
$3.0B
$149.8M
Q2 24
$3.0B
$80.4M
Total Assets
ACHC
ACHC
BNED
BNED
Q1 26
$5.5B
Q4 25
$5.5B
$1.1B
Q3 25
$6.4B
$950.8M
Q2 25
$6.3B
$790.3M
Q1 25
$6.1B
$1.1B
Q4 24
$6.0B
$1.0B
Q3 24
$5.9B
$973.2M
Q2 24
$5.7B
$909.9M
Debt / Equity
ACHC
ACHC
BNED
BNED
Q1 26
1.29×
Q4 25
1.28×
0.43×
Q3 25
0.74×
0.66×
Q2 25
0.74×
0.38×
Q1 25
0.72×
0.48×
Q4 24
0.64×
0.84×
Q3 24
0.62×
1.48×
Q2 24
0.62×
2.44×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACHC
ACHC
BNED
BNED
Operating Cash FlowLast quarter
$61.5M
$66.2M
Free Cash FlowOCF − Capex
$61.9M
FCF MarginFCF / Revenue
10.4%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
13.78×
2.65×
TTM Free Cash FlowTrailing 4 quarters
$-4.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACHC
ACHC
BNED
BNED
Q1 26
$61.5M
Q4 25
$-86.3M
$66.2M
Q3 25
$73.2M
$-67.6M
Q2 25
$133.5M
$52.6M
Q1 25
$11.5M
$-41.9M
Q4 24
$116.7M
$47.4M
Q3 24
$163.1M
$-143.5M
Q2 24
$171.1M
$81.7M
Free Cash Flow
ACHC
ACHC
BNED
BNED
Q1 26
Q4 25
$-179.5M
$61.9M
Q3 25
$-63.0M
$-71.3M
Q2 25
$-34.2M
$49.5M
Q1 25
$-163.2M
$-44.7M
Q4 24
$-86.8M
$44.4M
Q3 24
$-27.1M
$-147.5M
Q2 24
$16.9M
$79.1M
FCF Margin
ACHC
ACHC
BNED
BNED
Q1 26
Q4 25
-21.8%
10.4%
Q3 25
-7.4%
-26.0%
Q2 25
-3.9%
21.3%
Q1 25
-21.2%
-10.7%
Q4 24
-11.2%
7.9%
Q3 24
-3.3%
-58.8%
Q2 24
2.1%
41.1%
Capex Intensity
ACHC
ACHC
BNED
BNED
Q1 26
Q4 25
11.3%
0.7%
Q3 25
16.0%
1.4%
Q2 25
19.3%
1.3%
Q1 25
22.7%
0.7%
Q4 24
26.3%
0.5%
Q3 24
23.3%
1.6%
Q2 24
19.4%
1.4%
Cash Conversion
ACHC
ACHC
BNED
BNED
Q1 26
13.78×
Q4 25
2.65×
Q3 25
2.02×
Q2 25
4.43×
Q1 25
1.37×
-2.34×
Q4 24
3.58×
1.10×
Q3 24
2.39×
Q2 24
2.18×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACHC
ACHC

Acute Inpatient Psychiatric Facilities$471.0M57%
Other$140.0M17%
Specialty Treatment Facilities$128.0M15%
Residential Treatment Facilities$90.0M11%

BNED
BNED

Course Materials Product$459.3M77%
General Merchandise Product$112.9M19%
Serviceand Other$26.1M4%

Related Comparisons